Related Experiment Video
Updated: Aug 11, 2026
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
What's new in pediatric hypertension?
1Pediatric Nephrology, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. jflynn@montefiore.org
Current Hypertension Reports
|December 6, 2001
Summary
Pediatric hypertension research is growing, with new findings on childhood obesity-related hypertension, drug therapies, and ambulatory blood pressure monitoring. These advances improve diagnosis and treatment for hypertensive children.
Area of Science:
- Pediatrics
- Cardiology
- Public Health
Background:
- Pediatric hypertension is a growing concern.
- Obesity is a significant driver of hypertension in children.
- Current diagnostic and treatment strategies are evolving.
Purpose of the Study:
- To review recent advances in pediatric hypertension.
- To highlight the impact of obesity on childhood hypertension.
- To discuss new therapeutic approaches and monitoring techniques.
Main Methods:
- Literature review of recent research in pediatric hypertension.
- Focus on obesity-related hypertension, drug therapy, and ambulatory blood pressure monitoring.
- Synthesis of current findings and future directions.
Main Results:
- Significant increase in obesity-related hypertension among children.
- Advances in pharmacotherapy for childhood hypertension.
- Increased utilization of ambulatory blood pressure monitoring for diagnosis.
Conclusions:
- Continued research is crucial for understanding and managing pediatric hypertension.
- Addressing childhood obesity is key to preventing hypertension.
- Evolving monitoring and treatment strategies offer improved patient outcomes.
Related Concept Videos
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...